
Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowThe chart is not accessible to screen readers. Please switch to the table view to access the data.
It is estimated that between ** and ** percent of the millions of people suffering from post-traumatic stress disorder (PTSD) do not respond to regular treatment with selective serotonin reuptake inhibitors (FDA-approved). Similarly, traditional psychotherapy appears not to be effective for every patient. Between 2018 and 2020, a group of researchers tested the effectiveness of MDMA-assisted therapy on patients suffering from PTSD. After three sessions of MDMA-assisted therapy, over the course of 18 weeks, ** percent of the patients who received treatment still suffered from PTSD after the therapy sessions, therefore ** percent of these patients no longer met the diagnostic criteria for PTSD, compared to ** percent of the people who received a placebo.
Log in or register to access precise data.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
About the industry
About the region
Selected statistics
Other regions
Related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.